Literature DB >> 34047460

Impact of omalizumab on pollen-induced seasonal allergic rhinitis: An observational study in clinical practice.

Kojiro Hirano1, Isao Suzaki1, Shuhei Uruma1, Takatoshi Tokudome1, Shohei Matuura1, Mai Yano1, Sei Kobayashi2, Akihiko Tanaka3, Yuni Hirano4, Hideaki Watanabe4, Hitome Kobayashi1.   

Abstract

Entities:  

Keywords:  omalizumab; pollen; seasonal allergic rhinitis

Mesh：

Substances：

Year:  2021        PMID： 34047460     DOI： 10.1002/alr.22827

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN： 2042-6976            Impact factor:   3.858


× No keyword cloud information.
  2 in total

1.  Prevention of omalizumab for seasonal allergic rhinoconjunctivitis: a retrospective cohort study.

Authors:  Rui Tang; Shubin Lei; Liping Zhu; Yuzhen Lv; Hong Li
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

2.  Pharmacological Management of Allergic Rhinitis: A Consensus Statement from the Malaysian Society of Allergy and Immunology.

Authors:  Baharudin Abdullah; Amir Hamzah Abdul Latiff; Anura Michelle Manuel; Faizah Mohamed Jamli; Harvinder Singh Dalip Singh; Intan Hakimah Ismail; Jeevanan Jahendran; Jeyasakthy Saniasiaya; Kent Chee Keen Woo; Phaik Choo Khoo; Kuljit Singh; Nurashikin Mohammad; Sakinah Mohamad; Salina Husain; Ralph Mösges
Journal:  J Asthma Allergy       Date:  2022-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.